Pieris Pharmaceuticals
PIRS
#9791
Rank
S$24.36 M
Marketcap
$18.45
Share price
-15.58%
Change (1 day)
10.17%
Change (1 year)

Earnings for Pieris Pharmaceuticals (PIRS)

Earnings in 2024 (TTM): -S$29.86 Million

According to Pieris Pharmaceuticals's latest financial reports the company's current earnings are S$19.57 Million. In 2022 the company made an earning of -S$45.15 Million, an increase over its 2021 earnings that were of -S$62.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Pieris Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$29.86 Million
2022 -S$45.15 Million-27.24%
2021 -S$62.06 Million23.4%
2020 -S$50.29 Million45.53%
2019 -S$34.56 Million-5.89%
2018 -S$36.72 Million63.59%
2017 -S$22.45 Million-26.92%
2016 -S$30.72 Million63.39%
2015 -S$18.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.11 Billion 258.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$7.44 Million-75.21%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.23 B-895.62%๐Ÿ‡บ๐Ÿ‡ธ USA